{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:50:42Z","timestamp":1786992642904,"version":"build-2736575974"},"reference-count":21,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T00:00:00Z","timestamp":1551657600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck & Co., Inc.,","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.jiac.2019.02.012","type":"journal-article","created":{"date-parts":[[2019,3,15]],"date-time":"2019-03-15T02:52:50Z","timestamp":1552618370000},"page":"520-525","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Effectiveness on high-grade cervical abnormalities and long-term safety of the quadrivalent human papillomavirus vaccine in Japanese women"],"prefix":"10.1016","volume":"25","author":[{"given":"Masaru","family":"Sakamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etsuko","family":"Miyagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukari","family":"Sumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohzo","family":"Aisaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohiko","family":"Kuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Nagano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saiko","family":"Asahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi Rong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Wakana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Murata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyuki","family":"Sawata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 5","key":"10.1016\/j.jiac.2019.02.012_bib1","doi-asserted-by":"crossref","first-page":"F12","DOI":"10.1016\/j.vaccine.2012.07.055","article-title":"Global burden of human papillomavirus and related diseases","volume":"30","author":"Forman","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jiac.2019.02.012_bib2","series-title":"Human papillomavirus and related diseases report: world summary report","author":"Bruni","year":"2017"},{"key":"10.1016\/j.jiac.2019.02.012_bib3","series-title":"Human papillomavirus and related diseases report: Japan. Summary report. ICO information centre on HPV and cancer","author":"Bruni","year":"2017"},{"key":"10.1016\/j.jiac.2019.02.012_bib4","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.pvr.2018.10.001","article-title":"Single type infection of human papillomavirus as a cause for high-grade cervical intraepithelial neoplasia and invasive cancer in Japan","volume":"6","author":"Sakamoto","year":"2018","journal-title":"Papillomavirus Res"},{"key":"10.1016\/j.jiac.2019.02.012_bib5","first-page":"81","article-title":"Global delivery of human papillomavirus vaccines","volume":"63","author":"Wigle","year":"2016","journal-title":"Pediatr Clin"},{"key":"10.1016\/j.jiac.2019.02.012_bib6","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1086\/597071","article-title":"Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine","volume":"199","author":"Garland","year":"2009","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jiac.2019.02.012_bib7","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","author":"de Sanjose","year":"2010","journal-title":"Lancet Oncol"},{"issue":"Suppl 5","key":"10.1016\/j.jiac.2019.02.012_bib8","doi-asserted-by":"crossref","first-page":"F123","DOI":"10.1016\/j.vaccine.2012.04.108","article-title":"A\u00a0review of clinical trials of human papillomavirus prophylactic vaccines","volume":"30","author":"Schiller","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jiac.2019.02.012_bib9","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/cid\/ciw354","article-title":"Impact and effectiveness of the quadrivalent human papillomavirus vaccine: a systematic review of 10 years of real-world experience","volume":"63","author":"Garland","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2019.02.012_bib10","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/INF.0000000000000793","article-title":"An overview of quadrivalent human papillomavirus vaccine safety: 2006 to 2015","volume":"34","author":"Vichnin","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jiac.2019.02.012_bib11","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1056\/NEJMoa061760","article-title":"Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases","volume":"356","author":"Garland","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jiac.2019.02.012_bib12","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1056\/NEJMoa061741","article-title":"Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions","volume":"356","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jiac.2019.02.012_bib13","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40780-017-0087-6","article-title":"Safety of human papillomavirus vaccines in healthy young women: a meta-analysis of 24 controlled studies","volume":"3","author":"Ogawa","year":"2017","journal-title":"J\u00a0Pharm Health Care Sci"},{"key":"10.1016\/j.jiac.2019.02.012_bib14","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/cas.12106","article-title":"Efficacy of quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine (GARDASIL) in Japanese women aged 18-26 years","volume":"104","author":"Yoshikawa","year":"2013","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jiac.2019.02.012_bib15","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1111\/jog.13419","article-title":"Preventive effect of human papillomavirus vaccination on the development of uterine cervical lesions in young Japanese women","volume":"43","author":"Tanaka","year":"2017","journal-title":"J\u00a0Obstet Gynaecol Res"},{"key":"10.1016\/j.jiac.2019.02.012_bib16","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1158\/1940-6207.CAPR-09-0031","article-title":"A\u00a0pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6\/11\/16\/18) vaccine against high-grade cervical and external genital lesions","volume":"2","author":"Kjaer","year":"2009","journal-title":"Cancer Prev Res"},{"key":"10.1016\/j.jiac.2019.02.012_bib17","article-title":"Long-term effectiveness of the quadrivalent human papillomavirus vaccine in 16- to 23-year-old girls and women in four Nordic countries","author":"Kjaer","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2019.02.012_bib18","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S1473-3099(12)70187-1","article-title":"Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis","volume":"12","author":"Malag\u00f3n","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jiac.2019.02.012_bib19","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1080\/14760584.2017.1383158","article-title":"9-Valent human papillomavirus vaccine: a review of the clinical development program","volume":"16","author":"Luxembourg A Moeller","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.jiac.2019.02.012_bib20","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1080\/21645515.2017.1292190","article-title":"Realistic fear of cervical cancer risk in Japan depending on birth year","volume":"13","author":"Yagi","year":"2017","journal-title":"Hum Vaccine Immunother"},{"key":"10.1016\/j.jiac.2019.02.012_bib21","first-page":"241","article-title":"Human papillomavirus vaccines: WHO position paper","volume":"92","author":"World Health Organization (WHO)","year":"2017","journal-title":"Wkly Epidemiol Rec"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X18303027?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X18303027?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:58:40Z","timestamp":1761159520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X18303027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":21,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S1341321X18303027"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2019.02.012","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness on high-grade cervical abnormalities and long-term safety of the quadrivalent human papillomavirus vaccine in Japanese women","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2019.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}